NasdaqCM - Nasdaq Real Time Price USD
vTv Therapeutics Inc. (VTVT)
20.37
+0.06
+(0.30%)
As of 9:30:00 AM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
38,266
11,018
33,238
25,474
Total Liabilities Net Minority Interest
23,965
29,567
27,399
10,252
Total Equity Gross Minority Interest
14,301
-18,549
5,839
15,222
Total Capitalization
12,199
-24,680
-10,740
-9,740
Common Stock Equity
12,199
-24,680
-10,740
-9,740
Capital Lease Obligations
169
338
492
676
Net Tangible Assets
12,199
-24,680
-10,740
-9,740
Working Capital
32,917
38
19,386
7,123
Invested Capital
12,199
-24,489
-10,516
-9,484
Tangible Book Value
12,199
-24,680
-10,740
-9,740
Total Debt
169
529
716
932
Share Issued
2,612.26
2,084.97
2,037.09
1,673.57
Ordinary Shares Number
2,612.26
2,084.97
2,037.09
1,673.57
12/31/2021 - 7/30/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IGC IGC Pharma, Inc.
0.3051
+3.77%
OGEN Oragenics, Inc.
0.1926
-0.72%
TENX Tenax Therapeutics, Inc.
5.46
+7.06%
NBY NovaBay Pharmaceuticals, Inc.
0.5800
+0.49%
DSGN Design Therapeutics, Inc.
4.0350
-0.86%
ORKA Oruka Therapeutics, Inc.
10.44
-1.35%
KPRX Kiora Pharmaceuticals, Inc.
3.1800
+0.63%
STOK Stoke Therapeutics, Inc.
9.58
+0.58%
XTLB XTL Biopharmaceuticals Ltd.
1.2150
-7.25%
REVB Revelation Biosciences, Inc.
2.8800
+1.77%